EC Number: 691-729-9
CAS Number: 910463-68-2
IUPAC Name: 18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-m
Formulation Type: Injection and tablet formulations
Molecular Weight: 4114
Chemical Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Application: GLP-1 receptor agonist for type 2 diabetes, obesity, cardiovascular risk reduction

CNAS

FDA

GMP Formulation Facility

FDA- and GMP-compliant manufacturing site producing injectables

FDA inspections with zero Form 483 observations

FDA approval for oncology

Ratings

(0)

Comments

Filters:

Sort by:

No comments available.